ID
42199
Beskrivning
Study of STA-1 as an Add-on Treatment to Donepezil; ODM derived from: https://clinicaltrials.gov/show/NCT01255046
Länk
https://clinicaltrials.gov/show/NCT01255046
Nyckelord
Versioner (3)
- 2015-08-30 2015-08-30 -
- 2021-04-13 2021-04-13 - Dr. rer. medic Philipp Neuhaus
- 2021-11-18 2021-11-18 -
Uppladdad den
13 april 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Alzheimer Disease NCT01255046
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
Beskrivning
Exclusion Criteria
Beskrivning
brain image (computed tomography (ct) scan or magnetic resonance imaging (mri) done within past 12 months prior to the study) and laboratory tests to exclude secondary dementia or non-alzheimer's dementia;
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0024485
- UMLS CUI [1,2]
- C0040405
- UMLS CUI [1,3]
- C0587081
Beskrivning
patient with significant clinically central nervous system illness other than ad (e.g. parkinson's disease, human immunodeficiency virus (hiv) induced dementia, hachinski ischaemic score (his) >4) or dementia complicated by other organic disease or delirium;
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0007682
Beskrivning
patient with a severe or uncontrolled diagnostic and statistical manual of mental disorders (dsm-iv) axis i disorder other than alzheimer's disease, including amnestic disorders, schizophrenia or schizoaffective disorder, bipolar disorder, current major depressive episode, psychosis, panic, or post-traumatic stress disorder;
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0004936
Beskrivning
patient suffering from cerebral disturbances following a stroke or a cerebral trauma (if the event occurred within the last 6 months);
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0038454
- UMLS CUI [1,2]
- C0234387
Beskrivning
patient with a history of hypersensitivity to study drugs;
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0013182
Beskrivning
patient who has a history or evidence of a medical condition that would expose them to an undue risk of a significant adverse event or interfere with assessments of safety or efficacy during the course of the trial, including but not limited to hepatic, renal, respiratory, cardiovascular, endocrine (e.g., addison's disease), immune, neurologic, or hematologic disease as determined by the clinical judgment of the investigator;
Datatyp
boolean
Alias
- UMLS CUI [1]
- C3843040
Beskrivning
participation in any research study within the last 30 days;
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0008976
Beskrivning
patient with significant alcohol or drug abuse as judged by the investigator.
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0237123
Similar models
Eligibility Alzheimer Disease NCT01255046
- StudyEvent: Eligibility
CL386174 (UMLS CUI [2])
C0038454 (UMLS CUI [2])
C0677408 (UMLS CUI [2])
C0040405 (UMLS CUI [1,2])
C0587081 (UMLS CUI [1,3])
C0234387 (UMLS CUI [1,2])